Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

SHA:600161 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,898	2,686	4,555	3,713	4,330	1,748
Cash & Short-Term Investments	1,898	2,686	4,555	3,713	4,330	1,748
Cash Growth	-60.51%	-41.04%	22.68%	-14.25%	147.68%	23.69%
Accounts Receivable	2,297	1,121	94.13	1,173	1,027	695.59
Other Receivables	8.3	13.45	39.08	28.36	22.27	16.93
Receivables	2,305	1,134	133.21	1,201	1,050	712.52
Inventory	4,035	3,869	2,844	2,332	2,144	2,172
Other Current Assets	34.09	33.4	36.53	24.87	22.27	23.64
Total Current Assets	8,271	7,722	7,569	7,271	7,546	4,656
Property, Plant & Equipment	5,921	5,848	4,886	4,055	2,631	1,997
Long-Term Investments	143.2	143.2	146.06	146.06	146.06	121.59
Goodwill	572.15	572.15	173.92	173.92	127.93	115.01
Other Intangible Assets	881.88	917.05	686.88	441.63	370.99	252.44
Long-Term Deferred Tax Assets	61.84	41.77	46.74	60.63	67.01	63.11
Long-Term Deferred Charges	596.81	507.82	470.26	552.69	362.46	174.08
Other Long-Term Assets	103.03	117.66	208.66	228.88	326.85	161.34
Total Assets	16,551	15,870	14,188	12,929	11,578	7,541
Accounts Payable	95.88	81.45	179.1	69.39	73.7	45.86
Accrued Expenses	283.89	170.46	168.69	163.21	150.02	146.85
Short-Term Debt	145.56	-	-	-	-	200.13
Current Portion of Long-Term Debt	-	-	-	112.99	108.15	126.25
Current Portion of Leases	15.11	8.96	17.95	10.82	16.51	-
Current Income Taxes Payable	118.84	148.21	61.85	73.79	44.86	36.63
Current Unearned Revenue	191.24	213.19	357.26	292.72	215.31	200.66
Other Current Liabilities	524.74	498.07	494.78	434.44	201.03	182.98
Total Current Liabilities	1,375	1,120	1,280	1,157	809.58	939.36
Long-Term Debt	-	-	-	253.75	366.25	474.59
Long-Term Leases	70.35	44.86	24.42	25.62	18.01	-
Long-Term Unearned Revenue	103.48	107.44	99.56	101.9	92.69	80.83
Pension & Post-Retirement Benefits	-	-	-	-	-	0.06
Long-Term Deferred Tax Liabilities	53.52	62.44	28.85	30.87	20.14	11.15
Other Long-Term Liabilities	1.24	1.24	1.24	4.1	4.1	4.1
Total Liabilities	1,604	1,336	1,434	1,574	1,311	1,510
Common Stock	1,977	1,977	1,648	1,648	1,373	1,254
Additional Paid-In Capital	2,463	2,463	2,793	2,793	3,067	274.62
Retained Earnings	7,023	6,698	5,382	4,355	3,612	2,989
Comprehensive Income & Other	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1
Total Common Equity	11,463	11,139	9,823	8,795	8,052	4,518
Minority Interest	3,484	3,394	2,932	2,560	2,215	1,513
Shareholders' Equity	14,947	14,533	12,754	11,356	10,267	6,031
Total Liabilities & Equity	16,551	15,870	14,188	12,929	11,578	7,541
Total Debt	231.01	53.82	42.37	403.17	508.92	800.97
Net Cash (Debt)	1,667	2,632	4,513	3,310	3,821	947.15
Net Cash Growth	-65.03%	-41.68%	36.34%	-13.38%	303.40%	-6.48%
Net Cash Per Share	0.84	1.33	2.28	1.66	1.97	0.52
Filing Date Shares Outstanding	1,977	1,977	1,977	1,977	1,977	1,806
Total Common Shares Outstanding	1,977	1,977	1,977	1,977	1,977	1,806
Working Capital	6,896	6,602	6,290	6,113	6,736	3,717
Book Value Per Share	5.80	5.63	4.97	4.45	4.07	2.50
Tangible Book Value	10,009	9,650	8,962	8,180	7,553	4,150
Tangible Book Value Per Share	5.06	4.88	4.53	4.14	3.82	2.30
Buildings	-	2,711	2,241	1,957	963.02	949.32
Machinery	-	2,760	2,218	1,996	1,258	1,177
Construction In Progress	-	2,478	2,044	1,532	1,623	1,030

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.